Long-term follow-up of patients with chronic total coronary artery occlusion previously randomized to treatment with optimal drug therapy or percutaneous revascularization of chronic total occlusion (COMET-CTO)
Stefan Juričić(Center for Health, Exercise and Sport Sciences), Milorad Tešić(University of Belgrade), Vladan Vukčević(University of Belgrade), Dejan Milašinović(University of Belgrade), Miodrag Dikic, Milan Dobrić(Centar za Promociju Nauke), Branko Beleslin(University of Belgrade), Miloje Tomašević(University of Kragujevac), Goran Stanković(Population Health Research Institute), Milan Nedeljković(University of Belgrade), S Aleksandric(University of Belgrade), Dejan Orlić(University of Belgrade), Alfredo R. Galassi(AOL (United States)), Miodrag Ostojić(Institute for Cardiovascular Diseases of Vojvodina), Marko Banović(University of Belgrade), Siniša Stojković(University of Belgrade)
Cited by 18
Related Papers
Cardiopoietic Stem Cell Therapy in Heart Failure
|Journal of the American College of Cardiology|2013|485
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
|Circulation|2019|433
Global Chronic Total Occlusion Crossing Algorithm
|Journal of the American College of Cardiology|2021|229
Somatic DNA damage in interventional cardiologists: a case‐control study
|The FASEB Journal|2005|122
Lung Ultrasound and Pulmonary Congestion During Stress Echocardiography
|JACC. Cardiovascular imaging|2020|84